Great question! Vyvgart (efgartigimod) is a treatment that works by reducing harmful antibodies that interfere with nerve-to-muscle communication — which is at the root of MG symptoms like muscle weakness and fatigue.
It's currently FDA-approved for adults with generalized MG who test positive for AChR antibodies. There's Show Full Answer
Great question! Vyvgart (efgartigimod) is a treatment that works by reducing harmful antibodies that interfere with nerve-to-muscle communication — which is at the root of MG symptoms like muscle weakness and fatigue.
It's currently FDA-approved for adults with generalized MG who test positive for AChR antibodies. There's also exciting news — a recent Phase 3 trial showed it may help people who are seronegative (testing negative for common MG antibodies), and expanded approval could be submitted as early as end of 2025. As for how people find it, experiences can vary. Here are some things worth knowing:
- It's a targeted therapy, so eligibility depends on your antibody type
- If you're AChR-positive, it's already an option to discuss with your neurologist
- If you're seronegative, broader access may be coming soon
- Cost and access programs may be available through patient assistance organizations
Talking with your healthcare provider is the best way to find out if Vyvgart is right for your specific situation. Other MGteam members have shared that advocating for yourself and asking lots of questions at appointments really makes a difference! 💪
May 27
Join
Your Privacy Choices
